1-2 of 2
Juan Ke
Close
Sort by
Journal Articles

A comprehensive landscape of transcription profiles and data resources for human leukemia

Mei Luo, Ya-Ru Miao, Ya-Juan Ke, An-Yuan Guo, Qiong Zhang
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3435–3449.
https://doi.org/10.1182/bloodadvances.2022008410
Published: 2023
Includes: Supplemental data
Journal Articles

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Clinical Trials & Observations
Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque, Vasile Musteata, Jacek Treliński, Nichola Cooper, Peter Kiessling, Ute Massow, Franz Woltering, Rose Snipes, Juan Ke, Grant Langdon, James B. Bussel, Stephen Jolles
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4136–4146.
https://doi.org/10.1182/bloodadvances.2020002003
Published: 2020
Includes: Supplemental data